9

Both schools are collaborating on developing therapeutics based on findings of Howard Gendelman. Alabama is currently studying T cells in PWP and will tackle early phases of design (safety in humans, dosages, etc.) on the vaccine.

Parkinson Vaccine Announced

This is what I just do not understand...this question has essentially already been answered in Europe. I don't think clinical trials, which begin this year in Austria, would ignore the need to establish these things. Isn't this like two years of redundant effort? Affiris is beginning efficacy trials this year. If it is found that this vaccine does actually work in the way it is supposed to; isn't it inhumane for the FDA to not approve almost immediately usage of a similar vaccine, one that alters the very same misguided Alpha-synuclein.

In the meanwhile, how do we sign on for the trials in Austira? lol

Laura